Sigmapharm completes its 1st FDA inspection focused on its current GMP status and a Pre-Approval-Inspection related to its ANDA No. 079133.
Sigmapharm files its 1st Abbreviated New Drug Application (ANDA No. 079133).
Sigmapharm fully relocates to a new 60,000 sq. ft. facility located in Bensalem, Pennsylvania. Our new address is 3375 Progress Drive, Bensalem, PA 19020. Our new phone and fax numbers are (215) 352-6655 and (215) 352-6644, respectively.
Sigmapharm moves to a 5,000 sq. ft. facility located at the Oxford Valley Mall in Langhorne, Pennsylvania.
Dr. Spiro Spireas forms a new specialty pharmaceutical company, Sigmapharm Laboratories, LLC (“Sigmapharm”), on March 1, 2005.